Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 54903 dose-ranging placebo- and fluticasone-controlled phase 2 trial in asthma
2010-023167-17Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclesonide in asthma (5 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Mean change from randomization baseline to week 8 in trough FEV1. Started Jul 2011; status: terminated.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-023167-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023167-17.